Purchase Order 75F40124P00077

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to SB Drug Discovery LIMITED, a for-profit organization, to provide cultured cells stably expressing the human form of the NAV1.5 channel protein for use in in vitro electrophysiology and ion channel pharmacology projects. The contract has a ceiling value of $24,000.00 and was awarded on June 28, 2016 with a completion date of September 24, 2016. The award was not associated with any...

The U.S. Food and Drug Administration (FDA) awarded a $99,413.00 firm-fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, to conduct cardiotoxicity biomarker analysis on plasma samples from cancer patients. The contract has an ultimate completion date of September 29, 2025. This contract was awarded under a competitive solicitation that was set aside for small businesses under NAICS code 541380 - Testing Laboratories and Services....

The U.S. Food and Drug Administration (FDA) awarded a $106,675.00 firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for a proteomic analysis of cancer patient plasma samples. The contract, which has no set-aside designation, will be performed at Olink's facility in Waltham, Massachusetts and involves the comprehensive analysis of over 5,000 proteins across 100 plasma samples using Olink's advanced multiplex immunoassay...

The U.S. Food and Drug Administration awarded a firm fixed-price purchase order valued at $15,035 to Medchemexpress LLC, a New Jersey-based supplier of chemical compounds and research materials, for the FDA Drug Library project. The contract was awarded on July 13, 2018, with an ultimate completion date of July 20, 2018, and will be performed in Princeton, New Jersey. This procurement represents a non-set-aside award to support the FDA's research and development initiatives through the supply of...

<p>The U.S. Food and Drug Administration (FDA) awarded a $124,852.00 firm fixed-price purchase order to Sequoia Research Products LTD, a foreign-owned for-profit organization, for a &quot;DRUGS FOR RE-POSITIONING STUDY&quot; with an ultimate completion date of October 17, 2015. The contract was not set aside for any specific business type. The place of performance is in Great Britain, United Kingdom.</p>

This is a $147,501.31 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract, which has no set-aside designation, is for the acquisition of Olink's O-Link System and reagents. Olink Proteomics specializes in protein biomarker discovery solutions and has provided a variety of proteomics instruments, assay kits, and analysis services to support government research efforts,...

The Department of Health and Human Services Food and Drug Administration awarded a $727,122.40 firm fixed price purchase order to 3T Federal Solutions LLC of Austin, Texas. The contract calls for delivery of an automated high throughput patch clamp system to support the FDA's efforts to characterize drug effects on heart ion channels. The system must meet technical performance requirements to electrophysiologically assess individual cells at high volume, as requested in the small business...

The Food and Drug Administration awarded a $158,118.69 firm fixed-price purchase order to Fisher Scientific Company L.L.C. (doing business as Thermofisher Scientific) on July 23, 2025, for critical laboratory supplies supporting the Division of Applied Regulatory Science (DARS). The contract, which has no set-aside designation, will deliver 157 line items of scientific equipment and consumables including cell lines, cell media, chemicals, and other materials necessary for ongoing laboratory...

The Food and Drug Administration (FDA) awarded a $48,680.00 firm fixed price purchase order to Emulate Inc., a for-profit small business, for the purchase of Emulate Chip-S1 Basic Research Kits. This contract supports the FDA's regulatory science initiatives and advances the agency's work on non-animal testing approaches. The award has an ultimate completion date of August 21, 2025. Emulate Inc. has previously received federal grants, including a cooperative agreement from the Defense Advanced...

The Food and Drug Administration (FDA) awarded a $346,227.62 firm-fixed-price purchase order contract to Nanion Technologies Inc., a for-profit scientific instrumentation company, for a 5-year service maintenance plan for a SyncroPatch 384 system. The contract will provide preventative maintenance, technical support, software upgrades, and repairs for the equipment at the FDA facility in Silver Spring, Maryland. This contract was competed without a set-aside designation. The primary products and...